TRESMI | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

90 results for “TRESMI”

Trials

View all 57 →

PREMI trial

490 participants · First posted Oct 5, 2023

Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia

60 participants · First posted Aug 26, 2020

Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers

20 participants · First posted Jun 11, 2020

Drugs

View all 10 →

Investigational

Treamid

64Cu-TREM1-mAb

TREM2 Targeting Aptamers (Novartis)

Organizations

Trevi Therapeutics, Inc.

United States

Tres-Or Resources Ltd

Centre Hospitalier Interrégional Edith Cavell - Les Cliniques et Hôpitaux de la BasilIque, de Braine-l'Alleud - Waterloo, Edith Cavell, Lambermont, du Parc Léopold, Sainte-Anne Saint-Remi et de Delta

Belgium

News

View all 20 →

United Therapeutics Outlines 14 Planned Launches Across Pulmonary Fibrosis, Hypertension and Xenotransplantation

Ligand-Independent Strategies May Overcome Challenges in TREM-1 and TREM-2 Inhibition

Trevi Therapeutics Announces Clinical Trial Progress for Haduvio in Chronic Cough

Page 1 of 9